Abstract
The use of psychotropic medications in children has increased significantly in the last few years. There have been several case reports of sudden death in children taking specific psychotropic medications. Fears that these deaths might have been caused by ventricular arrhythmias have been enhanced by reports of electrocardiographic abnormalities, including prolongation of the QTc interval, in patients taking these medications. Several factors including genetic susceptibility, pre-existing cardiac disease, abnormalities of drug clearance and concomitant use of other medications known to affect the QTc interval can increase the susceptibility of the heart to conduction abnormalities. This article discusses the potential of particular psychotropic drugs to prolong the QTc interval in children, and examines other factors that may contribute to conduction abnormalities. We aim to provide clear clinical recommendations for the prescription of these drugs and the monitoring of children taking them.
Similar content being viewed by others
References
(1996) Unapproved uses of approved drugs: the physician, the package insert, and the Food and Drug Administration: subject review. American Academy of Pediatrics Committee on Drugs. Pediatrics 98:143–145
(2002) Treatment of ADHD in children with tics: a randomized controlled trial. Neurology 58:527–536
Alderman J (2005) Coadministration of sertraline with cisapride or pimozide: an open-label, nonrandomized examination of pharmacokinetics and corrected QT intervals in healthy adult volunteers. Clin Ther 27:1050–1063
Aman MG, De Smedt G, Derivan A, Lyons B, Findling RL (2002) Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. Am J Psychiatr 159:1337–1346
Amitai Y, Frischer H (2006) Excess fatality from desipramine in children and adolescents. J Am Acad Child Adolesc Psychiatr 45:54–60
Amital D, Amital H, Gross R, Kindler S, Zohar J (1994) Sinus bradycardia due to fluvoxamine overdose. Br J Psychiatr 165:553–554
Aronson MD, Hafez H (1986) A case of trazodone-induced ventricular tachycardia. J Clin Psychiatr 47:388–389
Balit CR, Isbister GK, Hackett LP, Whyte IM (2003) Quetiapine poisoning: a case series. Ann Emerg Med 42:751–758
Bauchner H (2000) ADHD: a new practice guideline from the American Academy of Pediatrics. Attention deficit hyperactive disorder. Arch Dis Child 83:63
Biederman J (1991) Sudden death in children treated with a tricyclic antidepressant. J Am Acad Child Adolesc Psychiatr 30:495–498
Biswas AK, Zabrocki LA, Mayes KL, Morris-Kukoski CL (2003) Cardiotoxicity associated with intentional ziprasidone and bupropion overdose. J Toxicol Clin Toxicol 41:101–104
Blair J, Scahill L, State M, Martin A (2005) Electrocardiographic changes in children and adolescents treated with ziprasidone: a prospective study. J Am Acad Child Adolesc Psychiatr 44:73–79
Blumer JL (1999) Off-label uses of drugs in children. Pediatrics 104:598–602
Bonati M, Clavenna A (2005) The epidemiology of psychotropic drug use in children and adolescents. Int Rev Psychiatr 17:181–188
Bont L, Bosker HA, Brus F, Yska JP, Bosch FH (1998) Torsade de pointes after pipamperone intoxication. Pharm World Sci 20:137
Bramble D (1997) Psychostimulants and British Child Psychiatrists. Child Psychol Psychiatr Rev 2:159–162
Bryant SM, Zilberstein J, Cumpston KL, Magdziarz DD, Costerisan DD (2003) A case series of ziprasidone overdoses. Vet Hum Toxicol 45:81–82
Catalano G, Catalano MC, Nunez CY, Walker SC (2001) Atypical antipsychotic overdose in the pediatric population. J Child Adolesc Psychopharmacol 11:425–434
Chalumeau M, Treluyer JM, Salanave B, Assathiany R, Cheron G, Crocheton N, Rougeron C, Mares M, Breart G, Pons G (2000) Off label and unlicensed drug use among French office based paediatricians. Arch Dis Child 83:502–505
Chandran KS (1994) ECG and clonidine. J Am Acad Child Adolesc Psychiatr 33:1351–1352
Chiu CC, Chang WH, Huang MC, Chiu YW, Lane HY (2005) Regular-dose risperidone on QTc intervals. J Clin Psychopharmacol 25:391–393
Citak A, Soysal DD, Ucsel R, Karabocuoglu M, Uzel N (2002) Efficacy of long duration resuscitation and magnesium sulphate treatment in amitriptyline poisoning. Eur J Emerg Med 9:63–66
Cohen H, Loewenthal U, Matar M, Kotler M (2001) Association of autonomic dysfunction and clozapine. Heart rate variability and risk for sudden death in patients with schizophrenia on long-term psychotropic medication. Br J Psychiatr 179:167–171
Combes A, Peytavin G, Theron D (2001) Conduction disturbances associated with venlafaxine. Ann Intern Med 134:166–167
Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT (1995) A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 80:795–803
Curtis LH, Masselink LE, Ostbye T, Hutchison S, Dans PE, Wright A, Krishnan RR, Schulman KA (2005) Prevalence of atypical antipsychotic drug use among commercially insured youths in the United States. Arch Pediatr Adolesc Med 159:362–366
Czekalla J, Beasley Jr CM, Dellva MA, Berg PH, Grundy S (2001) Analysis of the QTc interval during olanzapine treatment of patients with schizophrenia and related psychosis. J Clin Psychiatr 62:191–198
Dallaire S (2001) Thioridazine (Mellaril) and mesoridazine (Serentil): prolongation of the QTc interval. CMAJ 164:91, 95
de Boer RA, van Dijk TH, Holman ND, van Melle JP (2005) QT interval prolongation after sertraline overdose: a case report. BMC Emerg Med 5:5
de Meester A, Carbutti G, Gabriel L, Jacques JM (2001) Fatal overdose with trazodone: case report and literature review. Acta Clin Belg 56:258–261
Dineen S, Withrow K, Voronovitch L, Munshi F, Nawbary MW, Lippmann S (2003) QTc prolongation and high-dose olanzapine. Psychosomatics 44:174–175
Donmez O, Cetinkaya M, Canbek R (2005) Hemoperfusion in a child with amitriptyline intoxication. Pediatr Nephrol 20:105–107
dosReis S, Zito JM, Safer DJ, Gardner JF, Puccia KB, Owens PL (2005) Multiple psychotropic medication use for youths: a two-state comparison. J Child Adolesc Psychopharmacol 15:68–77
Drolet B, Rousseau G, Daleau P, Cardinal R, Simard C, Turgeon J (2001) Pimozide (Orap) prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium current in native cardiac myocytes. J Cardiovasc Pharmacol Ther 6:255–260
Dubnov G, Fogelman R, Merlob P (2005) Prolonged QT interval in an infant of a fluoxetine treated mother. Arch Dis Child 90:972–973
Durst R, Rosca-Rebaudengo P, Admon D (1994) Phenothiazine-associated supraventricular tachycardia. Aust NZ J Psychiatr 28:333–336
Efron D, Hiscock H, Sewell JR, Cranswick NE, Vance AL, Tyl Y, Luk ES (2003) Prescribing of psychotropic medications for children by Australian pediatricians and child psychiatrists. Pediatrics 111:372–375
Erfurth A, Loew M, Dobmeier P, Wendler G (1998) [ECG changes after paroxetine. 3 case reports]. Nervenarzt 69:629–631
Finlayson K, Witchel HJ, McCulloch J, Sharkey J (2004) Acquired QT interval prolongation and HERG: implications for drug discovery and development. Eur J Pharmacol 500:129–142
Flockhart DA, Drici MD, Kerbusch T, Soukhova N, Richard E, Pearle PL, Mahal SK, Babb VJ (2000) Studies on the mechanism of a fatal clarithromycin-pimozide interaction in a patient with Tourette syndrome. J Clin Psychopharmacol 20:317–324
Gbadebo TD, Trimble RW, Khoo MS, Temple J, Roden DM, Anderson ME (2002) Calmodulin inhibitor W-7 unmasks a novel electrocardiographic parameter that predicts initiation of torsade de pointes. Circulation 105:770–774
Gesell LB, Stephen M (2005) Toxicity following a single dose of risperidone for pediatric attention deficit hyperactivity disorder. J Toxicol Clin Toxicol 35:549
Gluais P, Bastide M, Grandmougin D, Fayad G, Adamantidis M (2004) Risperidone reduces K+ currents in human atrial myocytes and prolongs repolarization in human myocardium. Eur J Pharmacol 497:215–222
Goodnick PJ, Jerry J, Parra F (2002) Psychotropic drugs and the ECG: focus on the QTc interval. Expert Opin Pharmacother 3:479–498
Gutgesell H, Atkins D, Barst R, Buck M, Franklin W, Humes R, Ringel R, Shaddy R, Taubert KA (1999) Cardiovascular monitoring of children and adolescents receiving psychotropic drugs: A statement for healthcare professionals from the Committee on Congenital Cardiac Defects, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 99:979–982
Guy JM, Ndre-Fouet X, Porte J, Bertrand M, Lamaud M, Verneyre H (1991) [Torsades de pointes and prolongation of the duration of QT interval after injection of droperidol]. Ann Cardiol Angeiol (Paris) 40:541–545
Haddad PM, Anderson IM (2002) Antipsychotic-related QTc prolongation, torsade de pointes and sudden death. Drugs 62:1649–1671
Harrigan EP, Miceli JJ, Anziano R, Watsky E, Reeves KR, Cutler NR, Sramek J, Shiovitz T, Middle M (2004) A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition. J Clin Psychopharmacol 24:62–69
Hewer W, Rost W, Gattaz WF (1995) Cardiovascular effects of fluvoxamine and maprotiline in depressed patients. Eur Arch Psychiatr Clin Neurosci 246:1–6
Hochberg HM, Kanter D, Houser VP (1995) Electrocardiographic findings during extended clinical trials of fluvoxamine in depression: one years experience. Pharmacopsychiatry 28:253–256
Hoehns JD, Fouts MM, Kelly MW, Tu KB (2001) Sudden cardiac death with clozapine and sertraline combination. Ann Pharmacother 35:862–866
Hoehns JD, Stanford RH, Geraets DR, Skelly KS, Lee HC, Gaul BL (2001) Torsades de pointes associated with chlorpromazine: case report and review of associated ventricular arrhythmias. Pharmacotherapy 21:871–883
Horrigan JP, Barnhill LJ, Courvoisie HE (1997) Olanzapine in PDD. J Am Acad Child Adolesc Psychiatr 36:1166–1167
Hunt N, Stern TA (1995) The association between intravenous haloperidol and Torsades de Pointes. Three cases and a literature review. Psychosomatics 36:541–549
Isbister GK, Balit CR (2003) Bupropion overdose: QTc prolongation and its clinical significance. Ann Pharmacother 37:999–1002
Isbister GK, Bowe SJ, Dawson A, Whyte IM (2004) Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. J Toxicol Clin Toxicol 42:277–285
Isbister GK, Hackett LP (2003) Nefazodone poisoning: toxicokinetics and toxicodynamics using continuous data collection. J Toxicol Clin Toxicol 41:167–173
Isbister GK, Prior FH, Foy A (2001) Citalopram-induced bradycardia and presyncope. Ann Pharmacother 35:1552–1555
Jackson T, Ditmanson L, Phibbs B (1997) Torsade de pointes and low-dose oral haloperidol. Arch Intern Med 157:2013–2015
Jensen BT, Larroude CE, Rasmussen LP, Holstein-Rathlou NH, Hojgaard MV, Agner E, Kanters JK (2004) Beat-to-beat QT dynamics in healthy subjects. Ann Noninvasive Electrocardiol 9:3–11
Jervell A, Lange Nielsen F (1957) Congenital deaf-mutism, functional heart disease with prolongation of the Q–T interval and sudden death. Am Heart J 54:59–68
Kang J, Chen XL, Rampe D (2001) The antipsychotic drugs sertindole and pimozide block erg3, a human brain K(+) channel. Biochem Biophys Res Commun 286:499–504
Kautzner J, Yi G, Camm AJ, Malik M (1994) Short- and long-term reproducibility of QT, QTc, and QT dispersion measurement in healthy subjects. Pacing Clin Electrophysiol 17:928–937
Kelly CA, Dhaun N, Laing WJ, Strachan FE, Good AM, Bateman DN (2004) Comparative toxicity of citalopram and the newer antidepressants after overdose. J Toxicol Clin Toxicol 42:67–71
Kewley GD (1999) Risperidone in comorbid ADHD and ODD/CD. J Am Acad Child Adolesc Psychiatr 38:1327–1328
Krentz AJ, Mikhail S, Cantrell P, Hill GM (2001) Drug Points: Pseudophaeochromocytoma syndrome associated with clozapine. BMJ 322:1213
Kriwisky M, Perry GY, Tarchitsky D, Gutman Y, Kishon Y (1990) Haloperidol-induced torsades de pointes. Chest 98:482–484
Krulewicz S, Carpenter DJ, Fong R, Horrigan JP, Lipschitz A, Perera P, Wagner KD (2006) Analysis of electrocardiographic data following use of paroxetine in pediatric depression and obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatr 45:422–430
Kurth J, Maguire G (2004) Pediatric case report of quetiapine overdose and QTc prolongation. Ann Clin Psychiatr 16:229–231
Labellarte MJ, Crosson JE, Riddle MA (2003) The relevance of prolonged QTc measurement to pediatric psychopharmacology. J Am Acad Child Adolesc Psychiatr 42:642–650
Laird LK, Lydiard RB, Morton WA, Steele TE, Kellner C, Thompson NM, Ballenger JC (1993) Cardiovascular effects of imipramine, fluvoxamine, and placebo in depressed outpatients. J Clin Psychiatr 54:224–228
Landes GM, Curran ME, Keating MT (1995) Molecular characterization and refined genomic localization of three human potassium ion channel genes. Cytogenet Cell Genet 70:280–284
Langlois RP, Paquette D (1994) Sustained bradycardia during fluvoxamine and buspirone intoxication. Can J Psychiatr 39:126–127
Lasser KE, Allen PD, Woolhandler SJ, Himmelstein DU, Wolfe SM, Bor DH (2002) Timing of new black box warnings and withdrawals for prescription medications. JAMA 287:2215–2220
Letsas K, Korantzopoulos P, Pappas L, Evangelou D, Efremidis M, Kardaras F (2006) QT interval prolongation associated with venlafaxine administration. Int J Cardiol 109:116–117
Levenson JL (1999) Prolonged QT interval after trazodone overdose. Am J Psychiatr 156:969–970
Lin CH, Chen MC, Wang SY, Lin CY (2004) Predictive factors for QTc prolongation in schizophrenic patients taking antipsychotics. J Formos Med Assoc 103:437–441
Llerena A, Berecz R, Dorado P, de la Rubia A (2004) QTc interval, CYP2D6 and CYP2C9 genotypes and risperidone plasma concentrations. J Psychopharmacol 18:189–193
Lofton AL, Klein-Schwartz W (2005) Atypical experience: a case series of pediatric aripiprazole exposures. Clin Toxicol (Phila) 43:151–153
Maloney MJ, Schwam JS (1995) Clonidine and sudden death. Pediatrics 96:1176–1177
Mazur A, Strasberg B, Kusniec J, Sclarovsky S (1995) QT prolongation and polymorphous ventricular tachycardia associated with trasodone–amiodarone combination. Int J Cardiol 52:27–29
McCracken JT, McGough J, Shah B, Cronin P, Hong D, Aman MG, Arnold LE, Lindsay R, Nash P, Hollway J, McDougle CJ, Posey D, Swiezy N, Kohn A, Scahill L, Martin A, Koenig K, Volkmar F, Carroll D, Lancor A, Tierney E, Ghuman J, Gonzalez NM, Grados M, Vitiello B, Ritz L, Davies M, Robinson J, McMahon D (2002) Risperidone in children with autism and serious behavioral problems. N Engl J Med 347:314–321
McNicholas F (2001) Prescribing practices of child psychiatrists in the UK. Child Adolesc Mental Health 6:166–171
McNicholas F (2001) Psychotropic prescribing practices of paediatricians in the UK. Child Care Health Dev 27:497–508
Michalets EL, Smith LK, Van Tassel ED (1998) Torsade de pointes resulting from the addition of droperidol to an existing cytochrome P450 drug interaction. Ann Pharmacother 32:761–765
Michalets EL, Smith LK, Van Tassel ED (1998) Torsade de pointes resulting from the addition of droperidol to an existing cytochrome P450 drug interaction. Ann Pharmacother 32:761–765
Moltedo JM, Porter GA, State MW, Snyder CS (2002) Sinus node dysfunction associated with lithium therapy in a child. Tex Heart Inst J 29:200–202
Nissen SE (2006) ADHD drugs and cardiovascular risk. N Engl J Med 354:1445–1448
Nykamp DL, Blackmon CL, Schmidt PE, Roberson AG (2005) QTc prolongation associated with combination therapy of levofloxacin, imipramine, and fluoxetine. Ann Pharmacother 39:543–546
O’Brien JM, Rockwood RP, Suh KI (1999) Haloperidol-induced torsade de pointes. Ann Pharmacother 33:1046–1050
Ohtani H, Odagiri Y, Sato H, Sawada Y, Iga T (2001) A comparative pharmacodynamic study of the arrhythmogenicity of antidepressants, fluvoxamine and imipramine, in guinea pigs. Biol Pharm Bull 24:550–554
Pappadopulos E, Intyre Ii JC, Crismon ML, Findling RL, Malone RP, Derivan A, Schooler N, Sikich L, Greenhill L, Schur SB, Felton CJ, Kranzler H, Rube DM, Sverd J, Finnerty M, Ketner S, Siennick SE, Jensen PS (2003) Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II. J Am Acad Child Adolesc Psychiatr 42:145–161
Peano C, Leikin JB, Hanashiro PK (1997) Seizures, ventricular tachycardia, and rhabdomyolysis as a result of ingestion of venlafaxine and lamotrigine. Ann Emerg Med 30:704–708
Perrault LP, Denault AY, Carrier M, Cartier R, Belisle S (2000) Torsades de pointes secondary to intravenous haloperidol after coronary bypass grafting surgery. Can J Anaesth 47:251–254
Pohl R, Bridges M, Rainey Jr JM, Boudoulas H, Yeragani VK (1986) Effects of trazodone and desipramine on cardiac rate and rhythm in a patient with preexisting cardiovascular disease. J Clin Psychopharmacol 6:380–381
Popper C, Zimnitsky B (1995) Sudden-death putatively related to desipramine treatment in a youth: a fifth case and a review of speculative mechanisms. J Child Adolesc Psychopharmacol 5:283–300
Posey DJ, Walsh KH, Wilson GA, McDougle CJ (1999) Risperidone in the treatment of two very young children with autism. J Child Adolesc Psychopharmacol 9:273–276
Rappley MD, Eneli IU, Mullan PB, Alvarez FJ, Wang J, Luo Z, Gardiner JC (2002) Patterns of psychotropic medication use in very young children with attention-deficit hyperactivity disorder. J Dev Behav Pediatr 23:23–30
Ravina T, Suarez ML, Mendez-Castrillon J (1998) Fluoxetine-induced QTU interval prolongation, T wave alternans and syncope. Int J Cardiol 65:311–313
Reilly JG, Ayis SA, Ferrier IN, Jones SJ, Thomas SH (2000) QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet 355:1048–1052
Riddle MA, Geller B, Ryan N (1993) Another sudden death in a child treated with desipramine. J Am Acad Child Adolesc Psychiatr 32:792–797
Roden DM (1998) Taking the “idio” out of “idiosyncratic”: predicting torsades de pointes. Pacing Clin Electrophysiol 21:1029–1034
Roden DM (2004) Drug-induced prolongation of the QT interval. N Engl J Med 350:1013–1022
Romano C, Gemme G, Pongiglione R (1963) [Rare cardiac arrythmias of the pediatric age. II. Syncopal attacks due to paroxysmal ventricular fibrillation. (Presentation of 1st case in Italian pediatric literature)]. Clin Pediatr (Bologna) 45:656–683
Rothenhausler HB, Hoberl C, Ehrentrout S, Kapfhammer HP, Weber MM (2000) Suicide attempt by pure citalopram overdose causing long-lasting severe sinus bradycardia, hypotension and syncopes: successful therapy with a temporary pacemaker. Pharmacopsychiatr 33:150–152
Sala M, Vicentini A, Brambilla P, Montomoli C, Jogia JR, Caverzasi E, Bonzano A, Piccinelli M, Barale F, De Ferrari GM (2005) QT interval prolongation related to psychoactive drug treatment: a comparison of monotherapy versus polytherapy. Ann Gen Psychiatr 4:1
Sanguinetti MC, Jiang C, Curran ME, Keating MT (1995) A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell 81:299–307
Sawant S, Daviss SR (2004) Seizures and prolonged QTc with atomoxetine overdose. Am J Psychiatr 161:757
Scahill L, Leckman JF, Schultz RT, Katsovich L, Peterson BS (2003) A placebo-controlled trial of risperidone in Tourette syndrome. Neurology 60:1130–1135
Schirm E, Tobi H, Zito JM, de Jong-van den Berg LT (2001) Psychotropic medication in children: a study from the Netherlands. Pediatrics 108:E25
Schreier HA (1998) Risperidone for young children with mood disorders and aggressive behavior. J Child Adolesc Psychopharmacol 8:49–59
Schur SB, Sikich L, Findling RL, Malone RP, Crismon ML, Derivan A, Intyre Ii JC, Pappadopulos E, Greenhill L, Schooler N, Van Orden K, Jensen PS (2003) Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part I: a review. J Am Acad Child Adolesc Psychiatr 42:132–144
Schwartz PJ, Moss AJ, Vincent GM, Crampton RS (1993) Diagnostic criteria for the long QT syndrome. An update. Circulation 88:782–784
Shah RR (2005) Drug-induced QT dispersion: does it predict the risk of torsade de pointes? J Electrocardiol 38:10–18
Shah RR (2004) Drug-induced QT interval prolongation: regulatory perspectives and drug development. Ann Med 36(Suppl 1):47–52
Shapiro E, Shapiro AK, Fulop G, Hubbard M, Mandeli J, Nordlie J, Phillips RA (1989) Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette’s syndrome. Arch Gen Psychiatr 46:722–730
Shapiro LE, Shear NH (1999) Drug-drug interactions: how scared should we be? CMAJ 161:1266–1267
Shea S, Turgay A, Carroll A, Schulz M, Orlik H, Smith I, Dunbar F (2004) Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Pediatrics 114:e634–e641
Shimizu W, Antzelevitch C (2000) Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome. J Am Coll Cardiol 35:778–786
Siddiqui MA, Khan IA (2004) Nefazodone-associated torsade de pointes. Int J Cardiol 93:85–86
Slaveska K, Hollis C, Bramble D (1998) The use of antipsychotics by the child and adolescent psychiatrists. Psychiat Bull 22:685–687
Spiller HA, Lintner CP, Winter ML (2005) Atomoxetine ingestions in children: a report from poison centers. Ann Pharmacother 39:1045–1048
Stampfer H, Swanepoel P (2005) Severe tachycardia following low-dose clozapine treatment. Australas Psychiatr 13:80–82
Stollberger C, Huber JO, Finsterer J (2005) Antipsychotic drugs and QT prolongation. Int Clin Psychopharmacol 20:243–251
Su KP, Lane HY, Chuang CL, Chen KP, Shen WW (2004) Olanzapine-induced QTc prolongation in a patient with Wolff–Parkinson–White syndrome. Schizophr Res 66:191–192
Swanson JR, Jones GR, Krasselt W, Denmark LN, Ratti F (1997) Death of two subjects due to imipramine and desipramine metabolite accumulation during chronic therapy: a review of the literature and possible mechanisms. J Forensic Sci 42:335–339
Trenton A, Currier G, Zwemer F (2003) Fatalities associated with therapeutic use and overdose of atypical antipsychotics. CNS Drugs 17:307–324
Varley CK (2000) Sudden death of a child treated with imipramine. Case study. J Child Adolesc Psychopharmacol 10:321–325
Varley CK, McClellan J (1997) Case study: two additional sudden deaths with tricyclic antidepressants. J Am Acad Child Adolesc Psychiatr 36:390–394
Varma S, Achan K (1999) Dysrhythmia associated with clozapine. Aust NZ J Psychiatr 33:118–119
Varriale P (2001) Fluoxetine (Prozac) as a cause of QT prolongation. Arch Intern Med 161:612
Vieweg WV, Schneider RK, Wood MA (2005) Torsade de pointes in a patient with complex medical and psychiatric conditions receiving low-dose quetiapine. Acta Psychiatr Scand 112:318–322
Ward OC (1964) A New Familial Cardiac Syndrome In Children. J Ir Med Assoc 54:103–106
Weizman A, Weitz R, Szekely GA, Tyano S, Belmaker RH (1984) Combination of neuroleptic and stimulant treatment in attention deficit disorder with hyperactivity. J Am Acad Child Psychiatr 23:295–298
Welch R, Chue P (2000) Antipsychotic agents and QT changes. J Psychiatr Neurosci 25:154–160
Wernicke JF, Faries D, Girod D, Brown J, Gao H, Kelsey D, Quintana H, Lipetz R, Michelson D, Heiligenstein J (2003) Cardiovascular effects of atomoxetine in children, adolescents, and adults. Drug Saf 26:729–740
Wernicke JF, Kratochvil CJ (2002) Safety profile of atomoxetine in the treatment of children and adolescents with ADHD. J Clin Psychiatr 63(Suppl 12):50–55
Wilens TE, Biederman J, Baldessarini RJ, Geller B, Schleifer D, Spencer TJ, Birmaher B, Goldblatt A (1996) Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents. J Am Acad Child Adolesc Psychiatr 35:1491–1501
Wilens TE, Biederman J, March JS, Wolkow R, Fine CS, Millstein RB, Faraone SV, Geller D, Spencer TJ (1999) Absence of cardiovascular adverse effects of sertraline in children and adolescents. J Am Acad Child Adolesc Psychiatr 38:573–577
Wilting I, Smals OM, Holwerda NJ, Meyboom RH, de Bruin ML, Egberts TC (2006) QTc prolongation and torsades de pointes in an elderly woman taking fluoxetine. Am J Psychiatr 163:325
Yerrabolu M, Prabhudesai S, Tawam M, Winter L, Kamalesh M (2000) Effect of risperidone on QT interval and QT dispersion in the elderly. Heart Dis 2:10–12
Zito JM, Safer DJ, dosReis S, Gardner JF, Boles M, Lynch F (2000) Trends in the prescribing of psychotropic medications to preschoolers. JAMA 283:1025–1030
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
McNally, P., McNicholas, F. & Oslizlok, P. The QT interval and psychotropic medications in children. Eur Child Adolesc Psychiatry 16, 33–47 (2007). https://doi.org/10.1007/s00787-006-0573-0
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00787-006-0573-0